Tumor regression with regional distribution of the targeted toxin TF- CRM107 in patients with malignant brain tumors

Nature Medicine

Volumn 3, Issue 12, 1997, Pages 1362-1368

  Laske, Douglas W ^a,b   Youle, Richard J ^a   Oldfield, Edward H ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; TRANSFERRIN;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR REGRESSION; TUMOR VOLUME;

ADULT; AGED; ANTIBODIES; BRAIN; BRAIN NEOPLASMS; DIPHTHERIA TOXIN; DRUG DESIGN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TRANSFERRIN;

EID: 0031451777     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1297-1362     Document Type: Article

References (42)

1. Walker, A.E., Robins, M. & Weinfeld, F.D. Epidemiology of brain tumors: The national survey of intracranial neoplasms. Neurology 35, 219-226 (1985).
2. Mahaley, M.S., Jr., Mettlin, C., Natarajan, N., Laws, E.R., Jr., & Peace, B.B. National survey of patterns of care for brain-tumor patients. J. Neurosurg. 71, 826-836 (1989).
3. Salcman, M. Epidemiology and factors affecting survival. in Malignant Cerebral Glioma. (ed. Apuzzo, M.L.J.) 95-110 (Am. Assoc. of Neurol. Surgeons, Park Ridge, IL, 1990).
4. Larrick, J.W. & Cresswell, P. Modulation of cell surface iron transferrin receptors by cellular density and state of activation. J. Supramol. Struct. 11, 579-586 (1979).
5. Faulk, W.P., His, B.L. & Stevens, P.L. Transferrin and transferrin receptors in carcinoma of the breast. Lancet 11, 390-392 (1980).
6. Trowbridge, I.S. & Omary, M.B. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc. Natl. Acad. Sci. USA 78, 3039-3043 (1981).
7. Shindelman, A.E., Ortmeyer, A.E. & Sussman, H.H. Demonstration of the transferrin receptor in human breast cancer tissue: Potential marker for identifying dividing cells. Int. J. Cancer 27, 329-334 (1981).
8. Klausner, R.D. et al. Receptor mediated endocytosis of transferrin in K562 cells. J. Biol. Chem. 258, 4715-4724 (1983).
9. Gatter, K.C., Brown, G., Trowbridge, I.S., Woolston, R.E. & Mason, D.Y. Transferrin receptors in human tissues: Their distribution and possible clinical relevance. J. Clin. Pathol. 36, 539-545 (1983).
10. Zovickian, J.G., Johnson, V.G. & Youle, R.J. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin. J. Neurosurg. 66, 850-861 (1987).
11. Recht, L., Torres, C.O., Smith, T.W., Raso, V. & Griffin, T.W. Transferrin receptor in normal and neoplastic brain tissue: Implications for brain-tumor immunotherapy. J. Neurosurg. 72, 941-945 (1990).
12. Prior, R., Reifenberger, G. & Wechsler, W. Transferrin receptor expression in tumours of the human nervous system: Relation to tumour type, grading and tumour growth fraction. Virchows Archiv. A Pathol. Anat. 416, 491-496 (1990).
13. Jeffries, W.A. et al. Transferrin receptor on endothelium of brain capillaries. Nature 312, 162-163 (1984).
14. Connor, J.R. & Fine, R.E. The distribution of transferrin immunoreactivity in the rat central nervous system. Brain Res. 368, 319-328 (1986).
15. Greenfield, L., Johnson, V.G. & Youle, R.J. Mutations in Diphtheria toxin separate binding from entry and amplify immunotoxin selectivity. Science 238, 536-539 (1987).
16. Johnson, et al. Improved tumor specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia. J. Neurosurg. 70, 240-248 (1989).
17. Laske, D.W., Ilercil, O., Akbasak, A., Youle, R.J. & Oldfield, E.H. Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice. J. Neurosurg. 80, 520-526 (1994).
18. Garfield, J., Dayan, A.D. & Weller, R.O. Postoperative intracavitary chemotherapy of malignant supratentorial astrocytomas using BCNU. Clin. Oncol. 1, 213-222 (1975).
19. Kroin, J.S. & Penn, R.D. Intracerebral chemotherapy: Chronic microinfusion of cisplatin. Nerosurgery 10, 349-354 (1982).
20. Sendelbeck, S.L. & Urquhart, J. Spatial distribution of dopamine, methotrexate and antipyrine during continuous intracerebral microperfusion. Brain Res. 328, 251-258 (1985).
21. Jain, R.K. Delivery of novel therapeutic agents in tumors: Physiological barrier and strategies. J. Natl. Cancer Inst. 81, 570-576 (1989).
22. Brem, H. et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345, 1008-1012 (1995).
23. Bobo, R.H. et al. Convection-enhanced delivery of macromolecules in the brain. Proc. Natl. Acad. Sci. USA 91, 2076-2080 (1994).
24. Morrison, P.F., Laske, D.W., Bobo, R.H., Oldfield, E.H. & Dedrick, R.L. High-flow microinfusion: Tissue penetration and pharmacodynamics. Am. J. Physiol. 266, R292-R305 (1994).
25. Lieberman, D.M., Laske, D.W., Morrison, P.F., Bankiewicz, K.S. & Oldfield, E.H. Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J. Neurosurg. 82, 1021-1029 (1995).
26. Karnofsky, D.A. et al. Triethylene melamine in the treatment of neoplastic disease. Arch. Intern. Med. 87, 477-516 (1951).
27. Moolten, F.L. & Cooperband, S.R. Selective destruction of target cells by diphtheria toxin conjugated to antibody directed against antigens on the cells. Science 169, 68-70 (1970).
28. Thorpe, P.E. et al. Toxicity of diphtheria toxin for lymphoblastoid cells is increased by conjugation to antilymphocytic globulin. Nature 271, 752-755 (1978).
29. Gilliland, D.G. et al. Antibody-directed cytotoxic agents: Use of monoclonal antibody to direct the action of toxin A-chains to colorectal carcinoma cells. Proc. Natl. Acad. Sci. USA 77, 4539-4543 (1980).
30. Krolick, K.A., Villemez, C., Isakson, P., Uhr, J.W. & Vitetta, E.S. Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin. Proc. Natl. Acad. Sci. USA 77, 5419-5423 (1980).
31. Youle, R.J. & Neville, D.M., Jr. Anti-thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin. Proc. Natl. Acad. Sci. USA 77, 5483-5486 (1980).
32. Trowbridge, I.S. & Domingo, D.L. Anti-transferrin receptor monoclonal antibody and toxin-antibody conjugates affect growth of human tumour cells. Nature 294, 171-173 (1981).
33. Youle, R.J. & Colombatti, M. Monoclonal antibodies linked to toxic proteins for bone marrow transplantation and cancer therapy, in Monoclonal Antibodies in Cancer: Advances in Diagnosis and Treatment. (ed. Roth, J.A.) 173-213 (Futura Publishing Co., New York, 1986).
34. Pastan, I., Willingham, M.C. & Fitzgerald, D.J. Immunotoxins. Cell 47, 641-648(1986).
35. Vitetta, E.S., Fulton, R.J., May, R.D., Till, M. & Uhr, J.W. Redesigning nature's poisons to create anti-tumor reagents. Science 238, 1098-1104 (1987).
36. Vitetta, E.S. et al. Phase I immunotoxin trial in patients with B-cell lymphoma. Cancer Res. 51, 4052-4058 (1991).
37. Grossbard, M.L. et al. Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: A phase I trial of daily bolus infusion. Blood 79, 576-585 (1992).
38. Hesketh, P. et al. Clinical activity of a cytotoxic fusion protein in the treatment of cutaneous T-cell lymphoma. J. Clin. Oncol. 11, 1682-1690 (1993).
39. Spitler, L.E. et al. Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. Cancer Res. 47, 1717-1723 (1987).
40. Weiner, L.M. et al. Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate. Cancer Res. 49, 4062-4067 (1989).
41. Rybak, S.M. & Youle, RJ. Clinical use of immunotoxins: Monoclonal antibodies conjugated to protein toxins. Immunol. Allergy Clin. N. Am. 11, 359-380 (1991).
42. Johnson, V., Wilson, D., Greenfield, L. & Youle, R. The role of the diphtheria toxin receptor in cytosol translocation, J. Biol. Chem. 263, 1295-1300 (1988).